Literature DB >> 31202831

Radiation Oncologists' Role in End-of-Life Care: A Perspective From Medical Oncologists.

Jeffrey P Gross1, Jacqueline M Kruser2, Margaret R Moran3, Karen Kaiser3, Eytan Szmuilowicz4, Sheetal M Kircher5, Tim J Kruser6.   

Abstract

PURPOSE: Multidisciplinary communication and collaboration are key to planning and delivering end-of-life care for patients with advanced and metastatic cancer. We sought to characterize medical oncologists' perspectives on the role of radiation oncologists in end-of-life care.
MATERIALS AND METHODS: A sample of US medical oncologists was recruited using snowball sampling methods. Audio recordings of 4 professionally moderated focus groups were transcribed. Investigators from diverse backgrounds (medical oncology, radiation oncology, critical care medicine, palliative care, and public health) independently reviewed each transcript. Qualitative content analysis was used to create consensus codes that were applied to subsequent focus group transcripts in an iterative process.
RESULTS: Medical oncologists expressed complex views regarding the role of radiation oncologists in end-of-life care. Identified themes included the limited role of radiation oncologists, territorial concerns, capability, and desire of radiation oncologists in this realm, and the need for communication between providers. Radiation oncologists were compared with surgeons, whose interaction with patients ceased after their service had been performed. In this regard, control of palliative care referral or end-of-life care discussions was thought to be in the territory of medical oncologists who had longitudinal relationships with patients from diagnosis. Medical oncologists were concerned about the capability of radiation oncologists to accurately prognosticate, and stated radiation oncologists lacked knowledge of subsequent lines of systemic therapy available to patients. Radiation oncologists' fear of upsetting medical oncologists was thought to be justified if they engaged in end-of-life care planning without direct permission from the referring medical oncologist.
CONCLUSIONS: Participation of radiation oncologists in end-of-life care planning was viewed with skepticism by medical oncologists. Radiation oncologists should focus on increasing open communication and teamwork with medical oncologists and demonstrate their ability to prognosticate and counsel patients regarding end-of-life care decisions.
Copyright © 2019 American Society for Radiation Oncology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 31202831     DOI: 10.1016/j.prro.2019.04.001

Source DB:  PubMed          Journal:  Pract Radiat Oncol        ISSN: 1879-8500


  5 in total

1.  Goals of care discussions: perceptions of radiation and medical oncologists.

Authors:  Daniel Hong; Lauren C Das; Ellen Daily; Stacie K Levine; Olwen M Hahn; Stanley L Liauw; Daniel W Golden; Christina H Son
Journal:  Support Care Cancer       Date:  2021-05-25       Impact factor: 3.603

2.  Radiation oncology should be a partner to medical oncology in end-of-life care.

Authors:  Shearwood McClelland; Timur Mitin
Journal:  Rep Pract Oncol Radiother       Date:  2020-01-14

3.  Medical oncologist perspectives on palliative care reveal physician-centered barriers to early integration.

Authors:  Tim J Kruser; Jacqueline M Kruser; Jeffrey P Gross; Margaret Moran; Karen Kaiser; Eytan Szmuilowicz; Sheetal M Kircher
Journal:  Ann Palliat Med       Date:  2020-08-07

4.  Effect of Terminology Used to Describe Medical Oncologists on Perceptions of Radiation Oncologists as Equal Partners in Cancer Care.

Authors:  Malcolm D Mattes; Zachary White; Daniel W Golden; Neha Vapiwala; Joseph M Herman; Trevor J Royce
Journal:  Adv Radiat Oncol       Date:  2020-09-16

5.  "Connection Failed": A Word of Caution on Telemedicine in Radiation Oncology.

Authors:  Tobias Finazzi; Alexandros Papachristofilou; Frank Zimmermann
Journal:  Int J Radiat Oncol Biol Phys       Date:  2020-10-01       Impact factor: 7.038

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.